4DMedical Statistics

Total Valuation

4DMedical has a market cap or net worth of AUD 186.79 million. The enterprise value is 161.31 million.

Market Cap	186.79M
Enterprise Value	161.31M

Important Dates

The next estimated earnings date is Tuesday, November 26, 2024.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

4DMedical has 410.53 million shares outstanding. The number of shares has increased by 23.49% in one year.

Current Share Class	n/a
Shares Outstanding	410.53M
Shares Change (YoY)	+23.49%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	3.36%
Owned by Institutions (%)	1.34%
Float	326.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.90
PB Ratio	2.63
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.48
EV / Sales	42.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.20

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.07.

Current Ratio	1.78
Quick Ratio	1.67
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	-173.91

Financial Efficiency

Return on equity (ROE) is -50.54% and return on invested capital (ROIC) is -37.59%.

Return on Equity (ROE)	-50.54%
Return on Assets (ROA)	-26.95%
Return on Capital (ROIC)	-37.59%
Revenue Per Employee	25,891
Profits Per Employee	-248,129
Employee Count	145
Asset Turnover	0.04
Inventory Turnover	0.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.09% in the last 52 weeks. The beta is 1.26, so 4DMedical's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	-32.09%
50-Day Moving Average	0.52
200-Day Moving Average	0.56
Relative Strength Index (RSI)	38.07
Average Volume (20 Days)	625,135

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 4DMedical had revenue of AUD 3.75 million and -35.98 million in losses. Loss per share was -0.11.

Revenue	3.75M
Gross Profit	3.52M
Operating Income	-45.91M
Pretax Income	-35.93M
Net Income	-35.98M
EBITDA	-44.75M
EBIT	-45.91M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 30.61 million in cash and 5.12 million in debt, giving a net cash position of 25.49 million or 0.06 per share.

Cash & Cash Equivalents	30.61M
Total Debt	5.12M
Net Cash	25.49M
Net Cash Per Share	0.06
Equity (Book Value)	70.93M
Book Value Per Share	0.17
Working Capital	17.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.87 million and capital expenditures -156,109, giving a free cash flow of -31.02 million.

Operating Cash Flow	-30.87M
Capital Expenditures	-156,109
Free Cash Flow	-31.02M
FCF Per Share	-0.08

Full Cash Flow Statement

Margins

Gross Margin	93.69%
Operating Margin	-1,222.75%
Pretax Margin	-957.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-826.34%

Dividends & Yields

4DMedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.49%
Shareholder Yield	-23.49%
Earnings Yield	-24.18%
FCF Yield	-16.61%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

4DMedical has an Altman Z-Score of 0.06. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.06
Piotroski F-Score	n/a